Blog

Careers

Advertise

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2021
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2021
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
  • News

Comments of the Healthcare Supply Chain Association (HSCA) on FDA Request for Comments on Ensuring a Competitive Marketplace for Biosimilars

April 10, 2020 by Brigid Hasson 2019 Press Releases 0 comments

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the U.S. Food and Drug Administration’s (FDA) request for comments and holding of workshop on a competitive marketplace for biosimilars. HSCA is committed to increasing competition and promoting innovation in the healthcare system, and we applaud FDA for collaborating with the U.S. Federal Trade Commission (FTC) to ensure a competitive marketplace for biological products, including biosimilars and interchangeable products.

HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs), the sourcing and purchasing partners to virtually all of America’s 7,000+ hospitals, as well as the vast majority of the 68,000+ long-term care facilities, surgery centers, clinics, and other healthcare providers. GPOs work with healthcare providers to negotiate competitive prices and support a safe and reliable supply of healthcare products. We play a critical role in helping to lower costs for patients, providers, payers, Medicare and Medicaid, and taxpayers. One report estimated that GPOs reduce supply-related purchasing costs by 13.1 percent annually and will reduce healthcare spending by up to $456.6 billion between 2017 and 2026. The value that GPOs deliver allows healthcare providers and physicians to focus on their core mission: providing first-class patient care.

Click here to read the full comments.

Prev
Next

Related Posts

Joint Letter of Support for the MEDS Act
November 5, 2019

Dear Senator Collins and Senator Smith, The undersigned organizations are...

Learn more
HSCA Statement on FDA Drug Shortages Task Force Report
October 29, 2019

Washington, DC (October 29, 2019) – Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA Submits Comments to FDA on Using Unique Device Identifiers in Medical Device Safety Communications to Support Accuracy, Quality, and Patient Safety
January 18, 2021

Washington, DC (January 19, 2021) – The Healthcare Supply Chain Association...

Learn more
HSCA Applauds FDA for Releasing New Data to Enable Generic Competition
June 19, 2019

Washington, DC (June 19, 2019) – Healthcare Supply Chain Association (HSCA)...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA Submits Comments to FDA on Using Unique Device Identifiers in Medical Device Safety Communications to Support Accuracy, Quality, and Patient Safety
    January 18, 2021
  • HSCA Comments to the U.S. ITC on COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges
    October 5, 2020